跳至主要内容
临床试验/NCT02099162
NCT02099162Unknown不适用

Yonsei OCT (Optical Coherence Tomography) Registry for Evaluation of Efficacy and Safety of Coronary Stenting

Yonsei University1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2007年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
3,000
试验地点
1
主要终点
Comparison of OCT findings with physiologic findings

研究概览

简要总结

Optical coherence tomography (OCT) has been recently studied for evaluation of coronary stenting. Because of high resolutions, several reports have shown that OCT is appropriate for evaluating neointimal tissue after coronary stent implantation. Also, the strut coverage and the characterization of neointimal tissue can be accurately evaluated. Furthermore, OCT-defined coverage of a stent strut was proposed to be related with clinical safety in drug-eluting stents-treated patients. Therefore, the investigators will evaluate the appropriateness of currently using coronary stents (e.g. Sirolimus eluting stent, Paclitaxel-eluting stent, Zotarolimus-eluting stent, Everolimus-eluting stent, Biolimus eluting stent, EPC(endothelial progenitor cell) Capture stent, etc) based on the findings of OCT. Additionally, the investigators will evaluate neointimal hyperplasia, malposition or strut coverage to decide the differences in the stent characteristics, the duration of antiplatelet use, and the differences according to the clinical presentations.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with coronary stents
  • Patients who will have coronary stents because of coronary artery stenosis

排除标准

  • Hemodynamically unstable patients
  • Ostial lesions that begin within 15 mm of the left main coronary artery
  • Lesions with diameter more than 4 mm
  • Patients with allergy to antiplatelet agent (asprin or clopidogrel)
  • Patients with hepatic dysfunction (Liver enzyme 3 times the upper limit of normal)
  • Pregnant and lactating patients
  • Patients with life expectancy less than 1 year

结局指标

主要结局

Comparison of OCT findings with physiologic findings

时间窗: at index PCI, at follow-up coronary angiography (3, 6, 9 or 12 months and at the time clinically indicated)

OCT findings (stented lesions, native vessels)

时间窗: at index PCI, at follow-up coronary angiography (3, 6, 9 or 12 months and at the time clinically indicated)

Clinical outcomes

时间窗: up to 10 years

Death, Cardiac death, Stent thrombosis, Myocardial infarction, Target-lesion revascularization, Target-vessel revascularization

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验